G. Zaccone

发表

Risk Factors O-61 Could we predict post-operative hospitalization duration in cardiac surgical patients ?

A. Corona, S. Tommasini, M. Zucchetti, 2009 .

PROGNOSTIC ROLE OF POST-INFARCTION C-REACTIVE PROTEIN IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR PATIENTS: RESULTS OF THE CAMI GUIDE STUDY.

F. Crea, M. Sassara, M. Landolina, 2010 .

Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study.

R. Cappato, A. Curnis, G. Sinagra, 2010, International journal of cardiology.

Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report

E. Rota, L. Casalino, S. Agosti, 2017, Journal of Medical Case Reports.

Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life–threatening continuum of neuromuscular and cardiac toxicity

N. Morelli, E. Rota, E. Ghiglione, 2018, eNeurologicalSci.

Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study.

F. Crea, C. Klersy, A. Vado, 2012, European heart journal.

Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life-threatening continuum of neuromuscular and cardiac toxicity

E. Rota, E. Ghiglione, S. Agosti, 2019, Clinical Neurophysiology.

Minimal extracorporeal circulation (MECC): our experience: O-60

S. Tommasini, M. Zucchetti, V. Mazzei, 2007 .

Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study.

F. Crea, C. Klersy, A. Vado, 2012, European heart journal.